A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson&#39;s disease.

NTCELL (alginate-encapsulated neonatal porcine choroid plexus cells) - Living Cell Technologies

http://www.ncbi.nlm.nih.gov/pubmed/30503748

Dec 8, 2018